Douglas Kerr

Senior Director, Neurology Research & Development at Biogen MA, Inc.

Douglas Kerr

Douglas Kerr

Senior Director, Neurology Research & Development at Biogen MA, Inc.

Biography

Douglas Kerr is on the board of Triplet Therapeutics, Inc. and Chief Medical Officer for Generation Bio Co. In the past Dr. Kerr was Vice President-Neurology at Shire Plc. He received an MBA from Princeton University and a doctorate from Sidney Kimmel Medical College.

Overview

RelSci Relationships

800

Number of Boards

3

Birthday

1967

Age

53

Relationships

View Relationship Details

RelSci Relationships are individuals Douglas Kerr likely has professional access to. A relationship does not necessarily indicate a personal connection.

Kenneth Hobby

President at Cure SMA

Relationship likelihood: Strong

Jill Jarecki

Chief Scientific Officer at Cure SMA

Relationship likelihood: Strong

Mahendra Rao

Scientific Co-Founder at Q Therapeutics, Inc.

Relationship likelihood: Strong

Mary Schroth

Medical Director at Cure SMA

Relationship likelihood: Strong

Arthur H. Burghes

Professor at The Ohio State University - College of Medicine

Relationship likelihood: Strong

Elliot J. Androphy

Member, Scientific Advisory Board at Cure SMA

Relationship likelihood: Strong

Charlotte J. Sumner

Member, Scientific Advisory Board at Cure SMA

Relationship likelihood: Strong

Fred Troutman

Member, Medical Advisory Council at Cure SMA

Relationship likelihood: Strong

Kristin J. Krosschell

Member, Medical Advisory Council at Cure SMA

Relationship likelihood: Strong

Corey Braastad

Member, Board of Directors at Cure SMA

Relationship likelihood: Strong

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.

In The News

Business Wire

November 17, 2020

Triplet Therapeutics Appoints Kathy Biberstein, J.D., and Stephen Webster to its Board of Directors

RelSci

November 10, 2020

Douglas Kerr is now serving in a new position at Generation Bio Co.

GlobeNewswire

November 10, 2020

Generation Bio Reports Third Quarter 2020 Business Updates and Financial Results

Business Wire

December 17, 2019

Triplet Therapeutics Launches with $59 Million in Financing to Further its Development of Transformative Treatments for Triplet Repeat Disorders; - Triplet was formed by Atlas Venture and CEO Nessan Bermingham to create a new treatment paradigm for repeat

PR Newswire

March 6, 2018

Disarm Therapeutics Expands Scientific Advisory Board with Experts in Neurology, Neuropathy, and Axonal Degeneration

Paths to Douglas Kerr

Potential Connections via
Relationship Science

You

Douglas Kerr

Senior Director, Neurology Research & Development at Biogen MA, Inc.

Education

Princeton University

Princeton University is a vibrant community of scholarship and learning that stands in the nation's service and in the service of all nations. Chartered in 1746, Princeton is the fourth-oldest college in the United States. Princeton is an independent, coeducational, nondenominational institution that provides undergraduate and graduate instruction in the humanities, social sciences, natural sciences and engineering. As a world-renowned research university, Princeton seeks to achieve the highest levels of distinction in the discovery and transmission of knowledge and understanding. At the same time, Princeton is distinctive among research universities in its commitment to undergraduate teaching. Today, more than 1,100 faculty members instruct approximately 5,000 undergraduate students and 2,500 graduate students. The University's generous financial aid program ensures that talented students from all economic backgrounds can afford a Princeton education.

Sidney Kimmel Medical College

Career History

Chief Medical Officer

2019 - Current

Generation Bio Co.

Generation Bio Co. is a genetic medicines company focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. Its non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA; a novel cell-targeted lipid nanoparticle delivery system, or ctLNP; and an established, scalable capsid-free manufacturing process. The company was founded by Mark D. Angelino, Jason P. Rhodes, and Robert M. Kotin in 2016 and is headquartered in Cambridge, MA.

Senior Director, Neurology Research & Development

Current

Biogen MA, Inc.

Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA.

Advisor

Current

Atlas Venture, Inc.

Atlas Venture focuses on investments in early-stage companies operating in the fields of biotechnology. The firm partners with entrepreneurs to build companies around innovative science.

Public Holdings

Restricted data only for RelSci Professional users.

Other Affiliations

Douglas Kerr is affiliated with Generation Bio Co., Biogen MA, Inc., Atlas Venture, Inc.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Douglas Kerr. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Douglas Kerr's profile does not indicate a business or promotional relationship of any kind between RelSci and Douglas Kerr.